Home The crystal structure of 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate, C14H16N4O3
Article Open Access

The crystal structure of 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate, C14H16N4O3

  • Tai Xi-Shi ORCID logo , Zhou Xiao-Jing , Liu Li-Li , Zhang Ai-Ling EMAIL logo and Wang Li-Hua
Published/Copyright: November 4, 2020

Abstract

C14H16N4O3, orthorhombic, P21212 (no. 18), a = 8.0968(7) Å, b = 16.6829(17) Å, c = 5.3097(5) Å, V = 717.22(12) Å3, Z = 2, Rgt(F) = 0.0420, wRref(F2) = 0.0816, T = 293(2) K.

CCDC no.: 2036795

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.13 × 0.12 × 0.11 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.10 mm−1
Diffractometer, scan mode:SuperNova,
θmax, completeness:27.5°, 97%
N(hkl)measured, N(hkl)unique, Rint:2291, 1490, 0.025
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1224
N(param)refined:110
Programs:Bruker [1], Olex2 [2], Shelx [3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.2071 (2)0.46321 (10)0.9185 (3)0.0388 (5)
N10.0086 (3)0.45863 (12)0.6211 (4)0.0344 (6)
H1−0.065 (4)0.4362 (16)0.535 (5)0.043 (9)*
N20.2120 (3)0.08664 (13)0.7009 (4)0.0340 (6)
H210.244 (3)0.0603 (16)0.843 (5)0.041*
H220.143 (3)0.0603 (16)0.613 (5)0.041*
C10.0663 (3)0.29030 (15)0.5576 (5)0.0258 (6)
H1A0.00530.31630.43370.031*
C20.0859 (3)0.20834 (15)0.5456 (5)0.0271 (6)
H20.03700.17960.41530.033*
C30.1785 (3)0.16808 (15)0.7274 (4)0.0266 (6)
C40.2468 (3)0.21238 (16)0.9245 (5)0.0308 (6)
H40.30630.18631.04990.037*
C50.2271 (3)0.29412 (16)0.9353 (5)0.0303 (6)
H50.27510.32261.06690.036*
C60.1366 (3)0.33522 (15)0.7532 (4)0.0249 (6)
C70.1201 (3)0.42302 (15)0.7733 (4)0.0284 (6)
O20.50000.50000.6775 (5)0.0486 (8)
H2O0.42330.48620.77770.073*

Source of material

The synthetic method of 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate is as following: the mixture of 0.0755 g 4-aminobenzoic hydrazide (0.5 mmol), 0.0531 g thiocarbohydrazide (0.5 mmol) and neodymium(III) nitrate hexahydrate were dissolved in 20 mL (water-ethanol = 1:1) and continully stirred at 70 °C for 5.5 h. After cooled to room temperature, the solution was filtered to a small beaker. The colorless crystals of 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate were obtained by slow evaporation in 30 days.

Experimental details

The hydrogen atoms were positioned geometrically (C–H = 0.93 Å, N–H = 0.84–0.91 Å and O–H = 0.85 Å). Their Uiso values were set to 1.2Ueq or 1.5Ueq of the parent atoms.

Comment

Benzamide compounds may exhibit good biological activity in antitumor activity [5], [6], FGFR1 inhibitors [7], antibacterial agent [8], antialzheimer agent [9], and uPA inhibitor [10]. In our previous work, some benzamide compounds have been synthesized and structurally characterized [11], [12]. In this work, we synthesized a new benzamide compound, 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate, and its structure has also been determined.

The molecular structure of 4-amino-N′-(4-aminobenzoyl)benzohydrazide is shown in the Figure. The compound consists of one 4-amino-N′-(4-aminobenzoyl) benzohydrazide monohydrate molecule and one water molecule. The bond distance of C–O is 1.241(3) Å (C7–O1), which is similar to the C–O bond length [13], [14], indicating the C–O bond is double bond. The dihedral angle between two benzene rings ((C1–C2–C3–C4–C5–C6) and (C1A–C2A–C3A–C4A–C5A–C6A)) is 65.7°. In the crystal packing, the molecules form a 3D structure through N–H…O and O–H…O intermolecular hydrogen bonds.


Corresponding author: Zhang Ai‐Ling, College of Chemistry and Chemical Engineering, Weifang University, Weifang, Shandong261061, P. R. China, e-mail:

Award Identifier / Grant number: 21171132

Award Identifier / Grant number: ZR2014BL003

Funding source: Shandong Province Higher Educational Science and Technology Program

Award Identifier / Grant number: J14LC01

Funding source: Science Foundation of Weifang

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This project was supported by the National Natural Science Foundation of China (No. 21171132), the Natural Science Foundation of Shandong (ZR2014BL003), the project of Shandong Province Higher Educational Science and Technology Program (J14LC01) and Science Foundation of Weifang.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. Saint and Sadabs; Bruker Axs Inc.: Madison, Wisconsin, USA, 2000.Search in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

4. Brandenburg, K. Diamond. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Search in Google Scholar

5. Zhang, X., He, F., Zhang, Q., Lü, J., Xu, A., Yu, C., Qu, Y., Wu, J. Design, synthesis and evaluation of anti-tumor activities of chidamide derivatives. Chin. J. Org. Chem. 2019, 39, 1983–1989; https://doi.org/10.6023/cjoc201812036.Search in Google Scholar

6. Chen, T.‐P., Jiang, H.‐W., Zhou, J.‐J., Li, Z.‐C., Huang, W.‐C., Luo, Y.‐F., Zhao, Y.‐L. Synthesis of N-substituted benzamide derivatives and their evaluation as antitumor agents. Med. Chem. 2020, 16, 554–561; https://doi.org/10.2174/1573406415666190712120611.Search in Google Scholar

7. Xie, Z.‐X., Cheng, D.‐H., Luo, L., Shen, G.‐L., Pan, S.‐W., Pan, Y.‐Q., Chen, B., Wang, X.‐B., Liu, Z.‐G., Zhang, Y., Ye, F.‐Q. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer. J. Enzym. Inhib. Med. Chem. 2017, 138, 964–978. https://doi.org/10.1080/14756366.2018.1460824.Search in Google Scholar

8. Xia, J., Feng, B., Wen, G., Xue, W.‐J., Ma, G.‐X., Zhang, H.‐M., Wu, S. Bacterial lipoprotein biosynthetic pathway as a potential target for structure-based design of antibacterial agents. Curr. Med. Chem. 2020, 27, 1132–1150; https://doi.org/10.2174/0929867325666181008143411.Search in Google Scholar

9. Aliabadi, A., Mohammadi‐Farani, A., Bistouni, J.‐R. Synthesis and acetylcholinesterase inhibitory assessment of benzamide derivatives incorporated piperazine moiety as potential anti–Alzheimer agents. J. Pharmaceut. Sci. Res. 2017, 9, 1598–1603.Search in Google Scholar

10. Yu, H.‐Y., Gao, D., Zhang, X., Jiang, L.‐G., Hong, Z.‐B., Fang, X., Yuan, C., Wang, J.‐D., Huang, M.‐D. Synthesis of a weak basic uPA inhibitor and crystal structure of a complex with uPA. Chin. J. Struct. Chem. 2013, 32, 961–968.10.2210/pdb4h42/pdbSearch in Google Scholar

11. Tai, X.‐S., Wang, L.‐H, Liu, L.‐L., Zhou, X.‐J. The crystal structure of (E)-N′-((2-hydroxynaphthalen-1-yl)methylene)-2- phenylaceto-hydrazide. C19H16O2N2. Z. Kristallogr. NCS 2019, 234, 723–724. https://doi.org/10.1515/ncrs-2019-0074.Search in Google Scholar

12. Tai, X.‐S., Li, P.‐F. The crystal structure of (E)-N′-(pyridin-2-ylmethylene)pyrazine-2-carbohydrazide. C11H9N5O. Z. Kristallogr. NCS 2018, 233, 121–122. https://doi.org/10.1515/ncrs-2017-0208.Search in Google Scholar

13. Tai, X.‐S., Guo, H.‐M., Guo, Q.‐Q. Synthesis, crystal structure and antitumor activity of a novel Zn(II) complex with 2-(nicotinoyloxy)acetic acid ligand. Chin. J. Struct. Chem. 2018, 37, 1052–1056. https://doi.org/10.14102/j.cnki.0254-5861.2011-1880.Search in Google Scholar

14. Li‐Hua, W., Xi‐Shi, T., The crystal structure of (E)-N'‐(quinolin‐2‐ylmethylene)furan‐2‐carbohydrazide monohydrate, C15H13N3O3, Z. Kristallogr. Z. Kristallogr. NCS 2017, 232, 1038–1056. https://doi.org/10.1515/ncrs-2017-0170.Search in Google Scholar

Received: 2020-09-15
Accepted: 2020-10-13
Published Online: 2020-11-04
Published in Print: 2021-01-26

© 2020 Tai Xi‐Shi et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of 3-oxo-urs-12-en-28-oic acid, C30H46O3·1/6H2O
  4. The crystal structure of (3S,12R,20R,24R)-3,12-diacetyl-20,24-epoxy-dammarane-3,12,25–triol–ethyl acetate (4/1), C34H56O6⋅ 0.25(C4H8O2)
  5. A new polymorph of tetrakis(dimethylammonium) catena-poly[tetrakis(μ2-sulfato-κ2O:O′)dizinc(II)], Zn2C8H32N4O16S4
  6. Crystal structure of 10-oxysophoridine, C15H22N2O2
  7. The crystal structure of (5R,8R,9R,10R,12R,13R,14R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)tetradecahydro-3H-cyclopenta[a]phenanthrene-3,6(2H)-dione, C30H48O4
  8. Synthesis, crystal structure and optical property of 1,6-bis(p-tolylthio)pyrene, C30H22S2
  9. The crystal structure of hexakis(2-(pyridin-2-ylamino)pyridin-1-ium) decavanadate(V) dihydrate, C60H64N18O30V10
  10. Preparation and crystal structure of a cationic olefin polymerization precatalyst: (1,7-bis(2,6–dichlorophenyl)-1,7-di-aza-4-oxo-heptan-1,4,7-triyl)dimethyl zirconium(IV), C18H20Cl4N2OZr
  11. The crystal structure of fac-tricarbonyl(4,4-dimethyl-2,2-dipyridyl-κ2N,N′)- (pyrazole-κN)rhenium(I) nitrate, C18H16O3N4Re
  12. Synthesis and crystal structure of hexaaquacopper(II) 2,5-dicarboxyterephthalate, C10H16O14Cu
  13. The crystal structure of (8R,10R,12R,14R)- 12-hydroxy-16-(5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl)- 4,4,8,10,14-pentamethyltetradecahydro-3H- cyclopenta[a]phenanthrene-3,6(2H)-dione, C30H48O5
  14. Structure of the mixed crystal (S)-(6-(bromo/chloro)-2-methoxy-2,6-dihydroquinolin-3-yl)(phenyl)methanol, C17H14Br0.5Cl0.5NO2
  15. The crystal structure of trans-tetraaqua-bis(4-acetylphenoxyacetato-κ1O)manganese(II), C20H26O12Mn
  16. Crystal structure of (E)-2-(4-fluoro-3-(trifluoromethyl)benzylidene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  17. Crystal structure of DL-α-(methylaminomethyl)benzyl alcohol, C9H13NO
  18. The crystal structure of dipentaerthritol hexanitrate, C10H16N6O19
  19. Crystal structure of N,N-diphenylformamide, C13H11NO
  20. Crystal structure of (E)-2-(3,5-bis(trifluoromethyl)benzylidene)-7-methoxy-3,4-dihydronaphthalen- 1(2H)-one, C20H14F6O2
  21. Crystal structure of ortho-methoxy benzaldehyde, C8H8O2 – a second polymorph and deposition of 3D coordinates
  22. Crystal structure of catena-poly[diaqua-bis(μ2-2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanoato-κ2O:O')-(2-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanoato-κ2O,O')yttrium(III)], C51H79O11Y
  23. Crystal structure of benzylthiouronium chloride, C8H11ClN2S
  24. Synthesis and crystal structure of tert-butyl (2′R,3R,3′R,4aR,9aS)-1-acetyl-5-chloro-3″-methyl-2,5″,9′-trioxo-1″-phenyl-1″,4a′,5″,9a′-tetrahydro-1′H,3′H,9′H-dispiro[indoline-3,4′-xanthene-2′,4″-pyrazole]-3′-carboxylate, C36H32ClN3O7
  25. Crystal structure of 2-hydroxy-4-methoxy benzaldehyde, C8H8O3
  26. Crystal structure of poly[diaqua-(m3-3′,5′-dicarboxy-[1,1′-biphenyl]-3,4-dicarboxylato-K4O,O′:O″:O‴) cadmium(II)], C16H11O10Cd
  27. Crystal structure of {tetraaqua-bis(1-(4-hydroxy-2-oxotetrahydrofuran-3-yl)-2-((4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethane-1-sulfonato-k2O,O') calcium(II)}-{triaqua-bis(1-(4-hydroxy-2-oxotetrahydrofuran-3-yl)-2-((4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)ethane-1-sulfonato-k2O,O') calcium(II)} – water – acetone (1/1/8/2)
  28. Synthesis and crystal structure of bis{2-bromo-6-((E)-((4-((E)-1-(methoxy-imino)ethyl)phenyl)imino)methyl)phenolato- κ2N,O}zinc(II)-methanol(1/2), C65H60Br4N8O9Zn2
  29. Crystal structure of benzenesulphonic acid
  30. Crystal structure of N-benzyl-N-nicotinoyl-nicotine amide C19H15N3O2
  31. Crystal structure of poly[aqua(μ3-2,4-diamino-benzenesulfonato-κ4N:N′,O:O′)silver(I)], C12H18O8N4S2Ag2
  32. Crystal structure of 1,4-bis(methylpyridinium benzene) bis(1,2-dicyanoethene-1,2-dithiolato-κ2S:S)nickel(II), C26H18N6NiS4
  33. Crystal structure of the Cu(II) complex chlorido-(6-oxo-2-phenyl-1,6-dihydropyrimidine-4-carboxylato-k2N,O)-(phenanthroline-k2N,N')copper(II), C23H15ClCuN4O3
  34. Crystal structure of phenarsazine chloride acetic acid solvate, C14H13AsClNO2
  35. Crystal structure of poly[aqua-(μ2-3,3′,4,5′-biphenyl tetracarboxylate- κ3O,O′:O′′) -(μ2-4,4′-bis(pyrid-4-yl)biphenyl-κ2N:N′)zinc(II)], C27H18NO9Zn
  36. Crystal structure of catena-poly[(μ2-3-amino-benzenedisulfonato-κ2N:O)-bis (3-methyl-isoquinoline-κN)silver(I)], C26H24N3O3SAg
  37. Crystal structure of 2-((4-Aminophenyl)thio)acetic acid, C8H9NO2S
  38. Crystal structure of phenarsazine chloride dimethylsulfoxide solvate, C14H15AsClNOS
  39. Synthesis and crystal structure of 2-azido-N-phenylacetamide, C8H8N4O
  40. Crystal structure of chlorido{hydridotris[3-phenyl-5-methylpyrazol-1-yl-κN3]borato}copper(II), C30H28BClCuN6
  41. Crystal structure of benzanthrone – a redetermination for correct molecular geometry and localization of hydrogen atoms
  42. Crystal structure of 4-bromobenzaldehyde – complete redetermination at 200 K, C7H5BrO
  43. Crystal structure and spectroscopic properties of chlorido{hydridotris[3-,5-dimethylpyrazol-1-yl-κN3]borato}(3-,5-dimethylpyrazol-1-yl-κN)copper(II), C20H30BClCuN8
  44. The crystal structure of 4-((2-hydroxynaphthalen-1-yl)(pyrrolidin-1-yl)methyl)benzonitrile, C22H20N2O
  45. Crystal structure of 4-ethyl-3-phenylisoquinolin-1(2H)-one, C17H15NO
  46. Crystal structure of (tricyclohexylphosphane-κP)-[(Z)-N-(3-fluorophenyl)-O-methylthiocarbamato-k1S]gold(I), C26H40AuFNOPS
  47. Crystal structure of (3S,8R,10R,12R,14R)-12-hydroxy-4,4,8,10,14-pentamethyl-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl) hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, C32H54O4
  48. The crystal structure of 2-[(S)-1-(naphthalen-1-yl)ethyl]-2,3,7,7a- tetrahydro-3a,6-epoxyisoindol-1(6H)-one, C19H20NO2
  49. Crystal structure of {hydridotris[3-(t-butyl)-5-isopropylpyrazol-1-yl-κN3]borato}thallium(I), C30H52BN6Tl
  50. Synthesis and crystal structure of 1-octyl-3-phenylquinoxalin-2(1H)-one, C22H26N2O
  51. The crystal structure of 2,6-difluorophenol, C6H4F2O
  52. 4-(9H-Fluoren-9-yl)-4-methylmorpholin-4-ium bromide, C18H20BrNO
  53. The crystal structure of 2,4-dimethylimidazole monohydrate, C5H10N2O
  54. The crystal structure of 1,2-dimethylimidazole, C5H8N2
  55. The crystal structure of 3-ammonio-4-aminobenzoate, C7H8N2O2 – a second polymorph
  56. The crystal structure of 4-hydroxy-2,5-bis(1-methyl-1H-imidazol-3-ium-2-ylthio)-3,6-dioxocyclohexa-1,4-dienolate chloride monohydrate, C14H15N4O5S2Cl
  57. The crystal structure of butyrylferrocene, C14H16FeO
  58. The crystal structure of bi-1,1′-cyclopentane-1,1′-diol, C10H18O2
  59. The crystal structure of 2-iso-propylimidazole, C6H10N2
  60. The crystal structure of aqua-tris (1,3-diphenylpropane-1,3-dionato-κ2O,O′)-lanthanum(III), C45H35LaO7
  61. Crystal structure of (3E,5E)-3,5-bis-4-methoxy-3-(trifluoromethyl)benzylidene)-1-methylpiperidin-4-one, C24H21F6NO3
  62. The crystal structure of 3,5-dichloro-6-diazo-2,4-dinitrocyclohexa-2,4-dien-1-one, C6Cl2N4O5
  63. Crystal structure of carbonyl(2-methylquinolin-8-olato-κ2N,O)(triphenylarsine-κAs)rhodium(I), C29H23AsNO2Rh
  64. Crystal structure of (1aS,1a1S,2S)-4a-butoxy-1a,1a1,2,4a,5,6-hexahydro-1H-cyclobuta[de]naphthalen-2-yl-4-nitrobenzoate, C22H25NO5
  65. Crystal structure of carbonyl(2-oxopyridin-1(2H)-olato-k2O,O′)(triphenylarsine-κAs)rhodium(I), C24H19AsNO3Rh
  66. Crystal structure of catena-poly[triqua-bis(μ2-4-carboxy-2-(1H-tetrazol-1-yl)-1H-imidazole-5-carboxylato-k3N,O:O′)barium(II)] tetrahydrate, C14H14BaN12O15
  67. Crystal structure of (E)-3′,6′-bis(ethylamino)-2-((quinoxalin-2-ylmethylene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C35H32N6O2
  68. Crystal structure of diaqua-bis(μ2-5-chloro-salicylato-κ3O,O′:O′)-bis(5-chloro-salicylato-κ2O,O′)-bis(1,10-phenanthroline-κ2N,N′) dilead(II) – water (1/2), C52H36C14N4O14Pb2·2(H2O)
  69. Crystal structure of (E)-2-(4-ethoxycarbonyl-3,5-dimethyl-2-(pyrrole-2-ylmethyleneamino)-3′,6′-dihydroxylspiro[isoindoline-1,9′-xanthen]-3-one-methanol (1/1), C31H29N3O7
  70. The crystal structure of 5H-dibenzo[b,e]azepine-6,11-dione, C14H9NO2
  71. Crystal structure of (E)-2-(4-fluoro-2-(trifluoromethyl)benzylidene)-7-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  72. The crystal structure of N-(2-methoxy-4,5-bis[phenylselanyl]phenyl)picolinamide, C25H20N2O2Se2
  73. The crystal structure of (E)-2-(5-bromo-2-hydroxybenzylidene)-N-phenylhydrazine-1- carboxamide monohydrate, C14H14BrN3O3
  74. Crystal structure of fac-tricarbonyl-(nitrato-k1O)-bis(pyridine-κN)-rhenium, C13H10O6N3Re
  75. Crystal structure of (E)-2-(((1H-pyrrol-2-yl)methylene)amino)-3′,6′-dihydroxyspiro[isoindoline-1,9′-xanthen]-3-one — methanol (1/2), C27H25N3O6
  76. The crystal structure of 4-amino-N′-(4-aminobenzoyl)benzohydrazide monohydrate, C14H16N4O3
  77. Crystal structure of bis(amino(carbamothioylamino)methaniminium) 5-hydroxyisophthalate monohydrate, C12H20N8O6S2
  78. The crystal structure of 2-(chloromethyl)pyridine, C6H6ClN
  79. The crystal structure of 1-bromo-4-iodo-benzene, C6H4BrI
  80. The crystal structure of 2,6-dimethyl-4-nitro-phenol, C8H9NO3
  81. The crystal structure of 3-chloropropionic acid, C3H5ClO2
  82. The crystal structure of 2-(2-methoxyphenyl)acetic acid, C9H10O3
Downloaded on 14.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0476/html?srsltid=AfmBOorcrUO8i970jZbwi83Cc8m-AwHP4ymlDWWpLZHqnZsMRf8GUcQu
Scroll to top button